Cargando…

Differential replicative ability of clinical dengue virus isolates in an immunocompetent C57BL/6 mouse model

BACKGROUND: Several experimental animal models have been used to study the pathogenesis of dengue disease; however, most of the studies used laboratory-adapted viruses, which lack the virulence of viruses circulating in humans. The aim of this study was to analyze the ability of clinical Dengue viru...

Descripción completa

Detalles Bibliográficos
Autores principales: Barros, Veridiana Ester, dos Santos-Junior, Nilton Nascimento, Amarilla, Alberto Anastacio, Soares, Adriana Moreira, Lourencini, Rafael, Trabuco, Amanda Cristina, Aquino, Victor Hugo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4587874/
https://www.ncbi.nlm.nih.gov/pubmed/26415508
http://dx.doi.org/10.1186/s12866-015-0520-7
_version_ 1782392533308932096
author Barros, Veridiana Ester
dos Santos-Junior, Nilton Nascimento
Amarilla, Alberto Anastacio
Soares, Adriana Moreira
Lourencini, Rafael
Trabuco, Amanda Cristina
Aquino, Victor Hugo
author_facet Barros, Veridiana Ester
dos Santos-Junior, Nilton Nascimento
Amarilla, Alberto Anastacio
Soares, Adriana Moreira
Lourencini, Rafael
Trabuco, Amanda Cristina
Aquino, Victor Hugo
author_sort Barros, Veridiana Ester
collection PubMed
description BACKGROUND: Several experimental animal models have been used to study the pathogenesis of dengue disease; however, most of the studies used laboratory-adapted viruses, which lack the virulence of viruses circulating in humans. The aim of this study was to analyze the ability of clinical Dengue virus (DENV) isolates (D2/BR/RP/RMB/09 and D3/BR/SL3/02) to infect immunocompetent C57BL/6 mice. METHODS: Two strategies of intraperitoneal infection, which were based on the concept of the antibody dependent enhancement phenomenon, were used. In one strategy, the animals were inoculated with macrophages infected in vitro with dengue viruses, which were incubated with enhancing antibodies, and in the other strategy, the animals were inoculated with a complex of enhancing antibodies and dengue viruses. RESULTS: The D3/BR/SL3/08 isolate showed a higher ability of infection (virus RNA was more frequently detected in the serum and in several organs) in the experimental model compared to both the D2/BR/RP/RMB/2009 isolate and a laboratory adapted DENV-1 strain (Mochizuki strain), regardless of the infection strategy used. The main features of the D3/BR/SL3/08 isolate were its neuroinvasiveness and the induction of an extended period of viremia. Enhancing antibodies did not influence on the infection of animals when macrophages were used, but the level of viremia was increased when they were used as a complex with a D3/BR/SL3/02 isolate. DISCUSSION: We showed that DENV isolates could infect immunocompetent C57BL/6 mice, which have has been previously used to study some aspect of dengue disease when infected with laboratory adapted strains. DENV genome was detected in the same organs found in humans when autopsy and biopsy samples were analyzed, showing that C57BL/6 mice reproduce some aspects of the DENV tropism observed in humans. The main difference observed between the D3/BR/SL3/02 and D2/BR/RP/RMB/2009 clinical isolates was the neuroinvasive ability of the first one. Neuroinvasiveness has been described in some DENV infected cases and is common for other members of the Flavivirus genus. CONCLUSIONS: These results suggest that C57BL/6 mice can be used as an experimental model to evaluate virulence differences among DENV clinical isolates.
format Online
Article
Text
id pubmed-4587874
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-45878742015-09-30 Differential replicative ability of clinical dengue virus isolates in an immunocompetent C57BL/6 mouse model Barros, Veridiana Ester dos Santos-Junior, Nilton Nascimento Amarilla, Alberto Anastacio Soares, Adriana Moreira Lourencini, Rafael Trabuco, Amanda Cristina Aquino, Victor Hugo BMC Microbiol Research Article BACKGROUND: Several experimental animal models have been used to study the pathogenesis of dengue disease; however, most of the studies used laboratory-adapted viruses, which lack the virulence of viruses circulating in humans. The aim of this study was to analyze the ability of clinical Dengue virus (DENV) isolates (D2/BR/RP/RMB/09 and D3/BR/SL3/02) to infect immunocompetent C57BL/6 mice. METHODS: Two strategies of intraperitoneal infection, which were based on the concept of the antibody dependent enhancement phenomenon, were used. In one strategy, the animals were inoculated with macrophages infected in vitro with dengue viruses, which were incubated with enhancing antibodies, and in the other strategy, the animals were inoculated with a complex of enhancing antibodies and dengue viruses. RESULTS: The D3/BR/SL3/08 isolate showed a higher ability of infection (virus RNA was more frequently detected in the serum and in several organs) in the experimental model compared to both the D2/BR/RP/RMB/2009 isolate and a laboratory adapted DENV-1 strain (Mochizuki strain), regardless of the infection strategy used. The main features of the D3/BR/SL3/08 isolate were its neuroinvasiveness and the induction of an extended period of viremia. Enhancing antibodies did not influence on the infection of animals when macrophages were used, but the level of viremia was increased when they were used as a complex with a D3/BR/SL3/02 isolate. DISCUSSION: We showed that DENV isolates could infect immunocompetent C57BL/6 mice, which have has been previously used to study some aspect of dengue disease when infected with laboratory adapted strains. DENV genome was detected in the same organs found in humans when autopsy and biopsy samples were analyzed, showing that C57BL/6 mice reproduce some aspects of the DENV tropism observed in humans. The main difference observed between the D3/BR/SL3/02 and D2/BR/RP/RMB/2009 clinical isolates was the neuroinvasive ability of the first one. Neuroinvasiveness has been described in some DENV infected cases and is common for other members of the Flavivirus genus. CONCLUSIONS: These results suggest that C57BL/6 mice can be used as an experimental model to evaluate virulence differences among DENV clinical isolates. BioMed Central 2015-09-29 /pmc/articles/PMC4587874/ /pubmed/26415508 http://dx.doi.org/10.1186/s12866-015-0520-7 Text en © Barros et al. 2015 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Barros, Veridiana Ester
dos Santos-Junior, Nilton Nascimento
Amarilla, Alberto Anastacio
Soares, Adriana Moreira
Lourencini, Rafael
Trabuco, Amanda Cristina
Aquino, Victor Hugo
Differential replicative ability of clinical dengue virus isolates in an immunocompetent C57BL/6 mouse model
title Differential replicative ability of clinical dengue virus isolates in an immunocompetent C57BL/6 mouse model
title_full Differential replicative ability of clinical dengue virus isolates in an immunocompetent C57BL/6 mouse model
title_fullStr Differential replicative ability of clinical dengue virus isolates in an immunocompetent C57BL/6 mouse model
title_full_unstemmed Differential replicative ability of clinical dengue virus isolates in an immunocompetent C57BL/6 mouse model
title_short Differential replicative ability of clinical dengue virus isolates in an immunocompetent C57BL/6 mouse model
title_sort differential replicative ability of clinical dengue virus isolates in an immunocompetent c57bl/6 mouse model
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4587874/
https://www.ncbi.nlm.nih.gov/pubmed/26415508
http://dx.doi.org/10.1186/s12866-015-0520-7
work_keys_str_mv AT barrosveridianaester differentialreplicativeabilityofclinicaldenguevirusisolatesinanimmunocompetentc57bl6mousemodel
AT dossantosjuniorniltonnascimento differentialreplicativeabilityofclinicaldenguevirusisolatesinanimmunocompetentc57bl6mousemodel
AT amarillaalbertoanastacio differentialreplicativeabilityofclinicaldenguevirusisolatesinanimmunocompetentc57bl6mousemodel
AT soaresadrianamoreira differentialreplicativeabilityofclinicaldenguevirusisolatesinanimmunocompetentc57bl6mousemodel
AT lourencinirafael differentialreplicativeabilityofclinicaldenguevirusisolatesinanimmunocompetentc57bl6mousemodel
AT trabucoamandacristina differentialreplicativeabilityofclinicaldenguevirusisolatesinanimmunocompetentc57bl6mousemodel
AT aquinovictorhugo differentialreplicativeabilityofclinicaldenguevirusisolatesinanimmunocompetentc57bl6mousemodel